Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ventricular Remodeling | 15 | 2024 | 1265 | 2.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 25 | 2024 | 1048 | 2.000 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2023 | 575 | 1.780 |
Why?
|
Myocardial Ischemia | 8 | 2024 | 2110 | 1.320 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2024 | 1310 | 1.020 |
Why?
|
Myocardial Infarction | 16 | 2024 | 11459 | 1.000 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2024 | 1390 | 0.880 |
Why?
|
Coronary Artery Disease | 12 | 2023 | 6403 | 0.700 |
Why?
|
Fibrosis | 11 | 2024 | 2045 | 0.650 |
Why?
|
Coronary Circulation | 5 | 2021 | 1569 | 0.600 |
Why?
|
Contrast Media | 12 | 2022 | 5305 | 0.590 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36402 | 0.590 |
Why?
|
Ventricular Function, Left | 14 | 2024 | 3873 | 0.570 |
Why?
|
Esters | 1 | 2017 | 211 | 0.520 |
Why?
|
Exercise Test | 5 | 2024 | 2127 | 0.500 |
Why?
|
Cardiac Imaging Techniques | 2 | 2014 | 266 | 0.480 |
Why?
|
Myocardium | 10 | 2024 | 4724 | 0.470 |
Why?
|
Predictive Value of Tests | 20 | 2024 | 15251 | 0.470 |
Why?
|
Aortic Valve Stenosis | 2 | 2024 | 2003 | 0.460 |
Why?
|
Heart Ventricles | 6 | 2017 | 3796 | 0.460 |
Why?
|
Cardiomyopathies | 6 | 2023 | 1948 | 0.350 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2022 | 829 | 0.340 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 876 | 0.320 |
Why?
|
Heart Failure | 6 | 2024 | 11669 | 0.300 |
Why?
|
Atrial Function, Left | 3 | 2019 | 183 | 0.300 |
Why?
|
Stroke Volume | 11 | 2022 | 5486 | 0.300 |
Why?
|
Prognosis | 19 | 2024 | 29600 | 0.300 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2020 | 851 | 0.290 |
Why?
|
Phenotype | 3 | 2024 | 16571 | 0.290 |
Why?
|
Gadolinium | 4 | 2022 | 959 | 0.280 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2013 | 1725 | 0.270 |
Why?
|
Image Enhancement | 4 | 2022 | 2881 | 0.270 |
Why?
|
Risk Assessment | 11 | 2021 | 23972 | 0.260 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 3356 | 0.260 |
Why?
|
Heart Septum | 2 | 2017 | 299 | 0.260 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 557 | 0.250 |
Why?
|
Coronary Stenosis | 1 | 2011 | 794 | 0.250 |
Why?
|
Gadolinium DTPA | 4 | 2016 | 823 | 0.240 |
Why?
|
Hypertension | 1 | 2024 | 8529 | 0.230 |
Why?
|
Coronary Angiography | 2 | 2017 | 4470 | 0.230 |
Why?
|
Registries | 6 | 2023 | 8207 | 0.230 |
Why?
|
Myocarditis | 2 | 2023 | 788 | 0.230 |
Why?
|
Death, Sudden, Cardiac | 5 | 2024 | 1551 | 0.220 |
Why?
|
Fish Oils | 2 | 2018 | 483 | 0.220 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1515 | 0.210 |
Why?
|
Radiation Dosage | 1 | 2011 | 1956 | 0.210 |
Why?
|
Heart Diseases | 1 | 2015 | 2778 | 0.200 |
Why?
|
Humans | 64 | 2024 | 760617 | 0.190 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 322 | 0.190 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2017 | 2118 | 0.190 |
Why?
|
Perfusion | 2 | 2023 | 1373 | 0.180 |
Why?
|
Heart Atria | 2 | 2019 | 1333 | 0.180 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 148 | 0.180 |
Why?
|
Eicosapentaenoic Acid | 2 | 2024 | 561 | 0.170 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4058 | 0.170 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 100 | 0.160 |
Why?
|
Female | 43 | 2024 | 392148 | 0.160 |
Why?
|
Vasodilator Agents | 2 | 2014 | 973 | 0.150 |
Why?
|
Electrocardiography | 4 | 2024 | 6346 | 0.150 |
Why?
|
Heart Injuries | 1 | 2020 | 203 | 0.150 |
Why?
|
Male | 41 | 2024 | 360358 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3527 | 0.140 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5835 | 0.140 |
Why?
|
Prospective Studies | 13 | 2024 | 54360 | 0.140 |
Why?
|
Middle Aged | 35 | 2024 | 220584 | 0.140 |
Why?
|
Systole | 2 | 2017 | 935 | 0.140 |
Why?
|
Atrial Fibrillation | 4 | 2019 | 5031 | 0.140 |
Why?
|
Aged | 27 | 2024 | 169042 | 0.130 |
Why?
|
Echocardiography, Doppler | 2 | 2017 | 893 | 0.130 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 261 | 0.120 |
Why?
|
Algorithms | 2 | 2019 | 14018 | 0.120 |
Why?
|
Chest Pain | 1 | 2021 | 1091 | 0.110 |
Why?
|
Adiponectin | 1 | 2019 | 1107 | 0.110 |
Why?
|
Myocardial Revascularization | 1 | 2017 | 790 | 0.110 |
Why?
|
Nausea | 1 | 2016 | 679 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2013 | 196 | 0.110 |
Why?
|
Insulin Resistance | 2 | 2019 | 3954 | 0.100 |
Why?
|
Observer Variation | 5 | 2017 | 2606 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 907 | 0.100 |
Why?
|
Heart | 3 | 2021 | 4403 | 0.100 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20074 | 0.100 |
Why?
|
Risk Factors | 16 | 2024 | 74115 | 0.100 |
Why?
|
Cicatrix | 2 | 2020 | 785 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3900 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1028 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2041 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 607 | 0.100 |
Why?
|
Leptin | 1 | 2019 | 1595 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1185 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1418 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20556 | 0.090 |
Why?
|
Troponin T | 1 | 2016 | 780 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15828 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2017 | 628 | 0.090 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2015 | 324 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2190 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2013 | 306 | 0.090 |
Why?
|
Anthracyclines | 1 | 2012 | 285 | 0.090 |
Why?
|
Sarcomeres | 1 | 2013 | 368 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1718 | 0.090 |
Why?
|
Erythrocytes | 1 | 2019 | 2410 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39063 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4137 | 0.080 |
Why?
|
Aortic Valve | 1 | 2019 | 1955 | 0.080 |
Why?
|
Postmenopause | 1 | 2018 | 2511 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2234 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 64568 | 0.080 |
Why?
|
Double-Blind Method | 3 | 2019 | 12334 | 0.080 |
Why?
|
Coronary Vessels | 2 | 2024 | 3095 | 0.080 |
Why?
|
Tomography, Emission-Computed | 1 | 2012 | 1122 | 0.080 |
Why?
|
Mitral Valve | 1 | 2017 | 1464 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 539 | 0.080 |
Why?
|
Amyloidosis | 1 | 2015 | 815 | 0.080 |
Why?
|
Pulmonary Veins | 1 | 2013 | 716 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3769 | 0.070 |
Why?
|
Obesity | 3 | 2014 | 12933 | 0.070 |
Why?
|
Disease Progression | 7 | 2019 | 13495 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 975 | 0.060 |
Why?
|
Adult | 16 | 2024 | 220969 | 0.060 |
Why?
|
Organometallic Compounds | 2 | 2019 | 646 | 0.060 |
Why?
|
Patient Selection | 2 | 2017 | 4237 | 0.060 |
Why?
|
Defibrillators, Implantable | 3 | 2019 | 1483 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2013 | 2634 | 0.060 |
Why?
|
Models, Biological | 1 | 2019 | 9461 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2019 | 8998 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 80566 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14648 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 12447 | 0.050 |
Why?
|
Extracellular Space | 2 | 2013 | 562 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2017 | 5239 | 0.050 |
Why?
|
Lewy Body Disease | 1 | 2003 | 254 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6474 | 0.040 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2019 | 110 | 0.040 |
Why?
|
Proinsulin | 1 | 2019 | 135 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2019 | 22148 | 0.040 |
Why?
|
Alberta | 1 | 2019 | 68 | 0.040 |
Why?
|
Time Factors | 5 | 2024 | 39913 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 4987 | 0.040 |
Why?
|
Rodentia | 1 | 2020 | 261 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2118 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2019 | 158 | 0.040 |
Why?
|
ROC Curve | 2 | 2017 | 3575 | 0.040 |
Why?
|
United States | 2 | 2024 | 72272 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 427 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 440 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2013 | 3400 | 0.040 |
Why?
|
Uncertainty | 1 | 2021 | 752 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10760 | 0.030 |
Why?
|
Reference Values | 2 | 2014 | 4919 | 0.030 |
Why?
|
Hemodynamics | 2 | 2019 | 4160 | 0.030 |
Why?
|
Pilot Projects | 2 | 2024 | 8618 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10548 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2016 | 58894 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6807 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8699 | 0.030 |
Why?
|
Supine Position | 1 | 2014 | 205 | 0.030 |
Why?
|
Electric Countershock | 1 | 2016 | 532 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2020 | 932 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41457 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2506 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1096 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1656 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1635 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4242 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15498 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 843 | 0.020 |
Why?
|
Body Mass Index | 3 | 2014 | 12943 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 518 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2326 | 0.020 |
Why?
|
Genetic Testing | 1 | 2024 | 3533 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1575 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12043 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1288 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2018 | 1667 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2003 | 2878 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7237 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 30016 | 0.020 |
Why?
|
Young Adult | 4 | 2019 | 59179 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3599 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21337 | 0.020 |
Why?
|
Prevalence | 2 | 2014 | 15689 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2019 | 3411 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18381 | 0.020 |
Why?
|
Equipment Design | 1 | 2014 | 3501 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15576 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9586 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2459 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2634 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1884 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4110 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6224 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23717 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22131 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2003 | 42 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12116 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 88234 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3805 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3822 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8426 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9643 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4789 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5491 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12719 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15908 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9311 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12966 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6390 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13245 | 0.010 |
Why?
|
Homozygote | 1 | 2003 | 1776 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26049 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2013 | 17878 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14591 | 0.010 |
Why?
|
Heterozygote | 1 | 2003 | 2780 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 3302 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168201 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22115 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12142 | 0.010 |
Why?
|
Mice | 1 | 2013 | 81368 | 0.000 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_